Tracking Dendritic Cells in Cancer Immunotherapy Using MRI
Author Information
Author(s): Tavaré Richard, Sagoo Pervinder, Varama Gopal, Tanriver Yakup, Warely Alice, Diebold Sandra S., Southworth Richard, Schaeffter Tobias, Lechler Robert I., Razavi Reza, Lombardi Giovanna, Mullen Gregory E. D.
Primary Institution: King's College London
Hypothesis
Can superparamagnetic iron oxide (SPIO) labelling of dendritic cells (DCs) be used to monitor their migration and function in vivo during anti-tumour vaccination?
Conclusion
The study demonstrates that SPIO labelling does not adversely affect dendritic cell function and allows for effective monitoring of their migration in vivo.
Supporting Evidence
- SPIO labelling did not affect the viability or phenotype of dendritic cells.
- SPIO labelled dendritic cells were able to induce T cell proliferation comparable to unlabelled cells.
- Longitudinal MRI imaging showed similar migration patterns for SPIO labelled and unlabelled dendritic cells.
- SPIO labelled dendritic cells provided protection against tumour challenges in mice.
Takeaway
Researchers used a special dye to track immune cells in mice to see how they move and help fight cancer, and found that the dye didn't hurt the cells' ability to work.
Methodology
Dendritic cells were labelled with superparamagnetic iron oxide and their migration was monitored using MRI in a mouse model.
Potential Biases
Potential bias in interpreting MRI results due to the presence of SPIO in other cell types.
Limitations
The study primarily focused on murine models, which may not fully translate to human responses.
Participant Demographics
C57BL/6 and CBA/Ca mice were used in the study.
Statistical Information
P-Value
p<0.038
Confidence Interval
Not specified
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website